3β-hydroxy-5,24-cholestadiene - 98%, high purity , CAS No.313-04-2, Agonist of Liver X receptor-α;Agonist of Liver X receptor-β

Item Number
H400267
Grouped product items
SKUSizeAvailabilityPrice Qty
H400267-1mg
1mg
In stock
$45.90
H400267-5mg
5mg
In stock
$187.90

Basic Description

Synonyms110798 | AVSXSVCZWQODGV-DPAQBDIFSA-N | F87896 | NSC-226126 | NSC 226126 | 24-Dehydrocholesterol | cholest-5,24-dien-3beta-ol | DESMOSTEROL | SCHEMBL156561 | (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsStreptosterol is the cholesterol precursor in the Bloch pathway, and 24-dehydrocholesterol reductase plays a catalytic role in this step. The chain sterols accumulate during the depletion of 24-dehydrocholesterol reductase, leading to chain sterolization.
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeAGONIST
Mechanism of actionAgonist of Liver X receptor-α;Agonist of Liver X receptor-β

Associated Targets(Human)

RORC Tchem Nuclear receptor ROR-gamma (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NR1H2 Tchem Oxysterols receptor LXR-beta (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NR1H3 Tchem Oxysterols receptor LXR-alpha (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NR1H3 Tchem LXR-alpha (2891 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1H2 Tchem LXR-beta (3841 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
cyp125 Putative cytochrome P450 125 (56 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
INCHI InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9,19,21-25,28H,6,8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1
InChi Key AVSXSVCZWQODGV-DPAQBDIFSA-N
Canonical SMILES CC(CCC=C(C)C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C
Isomeric SMILES C[C@H](CCC=C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C
PubChem CID 439577
Molecular Weight 384.64

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDateItem
J2326392Certificate of AnalysisNov 03, 2023 H400267
J2326393Certificate of AnalysisNov 03, 2023 H400267
J2326434Certificate of AnalysisNov 03, 2023 H400267
B2318080Certificate of AnalysisFeb 23, 2023 H400267
B2318098Certificate of AnalysisFeb 23, 2023 H400267

Related Documents

Citations of This Product

1. Xu Xing, Chen Jun, Li Yan, Yang Xiaojie, Wang Qing, Wen Yanjun, Yan Ming, Zhang Jianjun, Xu Qin, Wei Yan, Chen Wantao, Wang Xu.  (2021)  Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma.  Cell Death & Disease,  12  (5): (1-15).  [PMID:33986254] [10.1038/s41419-021-03760-2]

References

1. Xu Xing, Chen Jun, Li Yan, Yang Xiaojie, Wang Qing, Wen Yanjun, Yan Ming, Zhang Jianjun, Xu Qin, Wei Yan, Chen Wantao, Wang Xu.  (2021)  Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma.  Cell Death & Disease,  12  (5): (1-15).  [PMID:33986254] [10.1038/s41419-021-03760-2]

Solution Calculators